Home › Autoimmune Diseases › Maryland › Baltimore
Autoimmune Diseases clinical trials in Baltimore, MD
6 studies for Autoimmune Diseases are looking for participants at sites in and around Baltimore (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
RecruitingPhase 2
- Johns Hopkins Hospital: Division of Rheumatology, Baltimore
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RecruitingPhase 1
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
RecruitingPhase 1
- Johns Hopkins Hospital, Baltimore
Daratumumab in Primary Antiphospholipid Syndrome
RecruitingPhase 1/2
- Johns Hopkins University, Baltimore
PS-002 for the Treatment of IgA Nephropathy in Adults
RecruitingPhase 1/2
- The Johns Hopkins Hospital, Baltimore
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecruitingObservational study
- Johns Hopkins, Baltimore
About Autoimmune Diseases
Autoimmune diseases are where your immune system attacks healthy cells in your body by mistake. Learn about the symptoms, tests, and treatments.
More about Autoimmune Diseases on MedlinePlus
Autoimmune Diseases trials in other cities
- Houston, TX21 studies
- Washington, DC19 studies
- New York City, NY19 studies
- Philadelphia, PA17 studies
- Durham, NC15 studies
- Boston, MA13 studies
- Chicago, IL13 studies
- Los Angeles, CA12 studies
- Atlanta, GA9 studies
- Dallas, TX9 studies
- Miami, FL8 studies
- Milwaukee, WI8 studies
Other studies in Baltimore
- Non-Small Cell Lung Cancer60 studies
- Prostate Cancer45 studies
- Breast Cancer44 studies
- Lung Cancer41 studies
- Cancer (all types)36 studies
- Colorectal Cancer30 studies
- Pancreatic Cancer30 studies
- Metastatic Cancer26 studies
- Obesity24 studies
- Bladder Cancer24 studies
- Ovarian Cancer23 studies
- Heart Failure23 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.